SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-044294
Filing Date
2021-08-13
Accepted
2021-08-13 16:01:48
Documents
68
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q isco-10q_20210630.htm   iXBRL 10-Q 2181730
2 EX-31.1 isco-ex311_7.htm EX-31.1 9310
3 EX-31.2 isco-ex312_9.htm EX-31.2 9321
4 EX-32.1 isco-ex321_8.htm EX-32.1 6048
5 EX-32.2 isco-ex322_6.htm EX-32.2 6619
  Complete submission text file 0001564590-21-044294.txt   9634038

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA isco-20210630.xsd EX-101.SCH 57790
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE isco-20210630_cal.xml EX-101.CAL 47385
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE isco-20210630_def.xml EX-101.DEF 190654
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE isco-20210630_lab.xml EX-101.LAB 417504
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE isco-20210630_pre.xml EX-101.PRE 321849
11 EXTRACTED XBRL INSTANCE DOCUMENT isco-10q_20210630_htm.xml XML 2376067
Mailing Address 5950 PRIESTLY DRIVE CARLSBAD CA 92008
Business Address 5950 PRIESTLY DRIVE CARLSBAD CA 92008 760-940-6383
International Stem Cell CORP (Filer) CIK: 0001355790 (see all company filings)

IRS No.: 204494098 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51891 | Film No.: 211171990
SIC: 2834 Pharmaceutical Preparations